Gabelli Healthcare & WellnessRx Trust
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$25M
Investors
41
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Gabelli Healthcare & WellnessRx Trust is a Delaware business trust that first filed a Form D on December 22, 2020 and most recently amended it on January 24, 2024, describing itself as a other investment fund. The offering claims Rule 506(b) and covers equity and pooled investment fund interests. Gabelli Healthcare & WellnessRx Trust reported $25,305,000 sold from 41 investors of a $36,680,000 total offering as of the Form D filed January 24, 2024. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is One Corporate Center, Rye, NY 10580-1422.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing January 24, 2024
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
3
latest Jan 24, 2024
Critical / warning
0 / 0
1 watch · 2 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
3
closed, dark
Latest event Sold increase · Jan 24, 2024
SEC.govInvestor
- 3 filing events with values and deltas, latest 2024-01-24, and alerts on the next one
- 3 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2024-01-24: 1 related person added and 1 removed against the filing of 2023-01-24; 16 now listed. The names are in the Terminal feed.
Mario J. Gabelli
Executive Officer, Director · Rye, NY
Trustee and Chief Investment Officer
James P. Conn
Director · Rye, NY
Trustee
Vincent D. Enright
Director · Rye, NY
Trustee
Jeffrey J. Jonas
Director · Rye, NY
Trustee
Robert C. Kolodny
Director · Rye, NY
Trustee
Anthonie C. van Ekris
Director · Rye, NY
Trustee
Salvatore J. Zizza
Director · Rye, NY
Trustee
John C. Ball
Executive Officer · Rye, NY
President, Treasurer and Principal Financial and Accounting Officer
Peter C. Goldstein
Executive Officer · Rye, NY
Secretary & Vice President
Richard J. Walz
Executive Officer · Rye, NY
Chief Compliance Officer
Bethany A. Uhlein
Executive Officer · Rye, NY
Vice President and Ombudsman
David I. Schachter
Executive Officer · Rye, NY
Vice President
Calgary I. Avansino
Director · Rye, NY
Trustee
Leslie F. Foley
Director · Rye, NY
Trustee
Agnes F. Mullady
Director · Rye, NY
Trustee
Adam E. Tokar
Executive Officer · Rye, NY
Vice President
Questions About Gabelli Healthcare & WellnessRx Trust
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Gabelli Healthcare & WellnessRx Trust?
Gabelli Healthcare & WellnessRx Trust is a Delaware business trust that filed a Form D with the SEC on January 24, 2024 as a other investment fund. The filing claims Rule 506(b) for an offering of equity and pooled investment fund interests.
Is Gabelli Healthcare & WellnessRx Trust legit?
AltStreet does not rate legitimacy; it reports the public record. Gabelli Healthcare & WellnessRx Trust filed a Form D with the SEC on January 24, 2024 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $25,305,000 sold to 41 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Gabelli Healthcare & WellnessRx Trust registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Gabelli Healthcare & WellnessRx Trust claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Gabelli Healthcare & WellnessRx Trust raised?
Gabelli Healthcare & WellnessRx Trust reported $25,305,000 sold from 41 investors of a $36,680,000 total offering as of the Form D filed January 24, 2024.
Who can invest in Gabelli Healthcare & WellnessRx Trust?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in Gabelli Healthcare & WellnessRx Trust?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling Gabelli Healthcare & WellnessRx Trust and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Gabelli Healthcare & WellnessRx Trust?
The Form D lists 16 related persons: Mario J. Gabelli, executive officer, director (Trustee and Chief Investment Officer); James P. Conn, director (Trustee); Vincent D. Enright, director (Trustee); Jeffrey J. Jonas, director (Trustee); Robert C. Kolodny, director (Trustee); Anthonie C. van Ekris, director (Trustee); Salvatore J. Zizza, director (Trustee); John C. Ball, executive officer (President, Treasurer and Principal Financial and Accounting Officer), and 8 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Gabelli Healthcare & WellnessRx Trust located?
The issuer's address on its SEC filings is One Corporate Center, Rye, NY 10580-1422. Its phone number of record is 914-921-5100. It is organized under the laws of Delaware.
How long is the Gabelli Healthcare & WellnessRx Trust offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
How large is Gabelli Healthcare & WellnessRx Trust?
The issuer declined to disclose its net asset value range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
